Dr Braddy-Green is involved in research aimed at advancing the care and management of patients with inflammatory bowel disease. He is a member of the BSG IBD Guideline Development Group and PI in the GONDOMAR trial (Goals, Needs and outcome Determinants Of Multimodal therapy in Perianal Crohn's fistula - A multicentre cohort study).
Gordon, M., Darie, A., Sinopoulou, V., et al. BSG 2024 IBD guidelines protocol (standard operating procedures). BMJ Open Gastroenterology 2023;10:e001067.
Dr Braddy-Green has also published work on cytomegalovirus infections and treatment mutations.
Lumley, S., Green, C., Rafferty, H., Smith, C., Harber, M., O’Beirne, J., et al. (2019). Cytomegalovirus viral load parameters associated with earlier initiation of pre emptive therapy after solid organ transplantation. PLoS ONE 14(1): e0210420.
Green, C., O’Riordan, A., Griffiths, P., & Haque, T. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report. J Clin Virology. 80 (2016) 24 – 26.